Relx (NYSE:RELX – Get Free Report) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research report issued on Friday, Marketbeat Ratings reports.
A number of other equities analysts have also recently issued reports on RELX. Redburn Atlantic assumed coverage on shares of Relx in a report on Wednesday, January 8th. They issued a “buy” rating on the stock. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th.
View Our Latest Analysis on RELX
Relx Trading Up 0.1 %
Institutional Trading of Relx
Several institutional investors and hedge funds have recently bought and sold shares of the stock. FMR LLC boosted its holdings in shares of Relx by 8.3% in the third quarter. FMR LLC now owns 7,148,837 shares of the technology company’s stock worth $339,284,000 after buying an additional 548,423 shares during the period. Bank of America Corp DE lifted its holdings in shares of Relx by 4.2% in the fourth quarter. Bank of America Corp DE now owns 6,246,462 shares of the technology company’s stock valued at $283,714,000 after purchasing an additional 253,107 shares in the last quarter. Lazard Asset Management LLC boosted its position in Relx by 1.2% during the 4th quarter. Lazard Asset Management LLC now owns 4,224,334 shares of the technology company’s stock worth $191,868,000 after acquiring an additional 48,793 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Relx by 4.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,189,886 shares of the technology company’s stock worth $144,885,000 after purchasing an additional 121,831 shares during the period. Finally, Ameriprise Financial Inc. increased its stake in Relx by 368.7% in the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company’s stock valued at $127,437,000 after buying an additional 2,208,119 shares during the period. Institutional investors and hedge funds own 15.02% of the company’s stock.
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories
- Five stocks we like better than Relx
- Pros And Cons Of Monthly Dividend Stocks
- D-Wave Quantum Stock Jumps on “Quantum Supremacy” News
- Compound Interest and Why It Matters When Investing
- How Taiwan Semiconductor’s U.S. Move Could Shift Chipmaking
- 3 Small Caps With Big Return Potential
- Crypto Crash Hits These 4 Blockchain Stocks—Is It Time to Buy?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.